CLINICAL_TRIALS
trial_result
· 2025-12-29
Clinical Trial Update: A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma [Phase 1]
Summary
A Phase I study of a personalized neoantigen cancer vaccine in melanoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Patrick Ott, MD, PhD | Conditions: Melanoma | Phase 1 | Status: COMPLETED | Results posted: 2025-12-29